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ORIGINAL ARTICLE  
FREQUENCY, INDICATIONS AND COMPLICATIONS OF PULMONARY 
ARTERY CATHETER INSERTION IN ADULT OPEN-HEART SURGERY 
PATIENTS OF A TERTIARY CARE HOSPITAL 
Syed Shabbir Ahmed, Mohammad Irfan Akhtar, Rehana Kamal 
Department of Anaesthesiology, Aga Khan University, Karachi-Pakistan 
Background: Patients presenting for cardiac surgery have unstable cardiovascular disease 
and haemodynamics with multiple coexisting diseases. Optimal monitoring in the 
perioperative period is very important for best perioperative outcome. The introduction of the 
flow-directed pulmonary artery catheter (PAC) into clinical practice is one of the most 
important and popular advances in the field of cardiac anaesthesia. The objective of the study 
was to determine the frequency, indications and complications of pulmonary artery catheter 
insertion in adult open-heart surgery patients. Methods: A Prospective observational study 
was conducted at cardiac operating rooms and Cardiac Intensive care unit (CICU) of Aga 
Khan University Hospital for a period of six months from Nov 2015 to April 2016.Two 
hundred and seven patients were included in this study. PAC was inserted through right/left 
internal jugular vein or subclavian vein. Complications noted were arrhythmias (atrial and 
ventricular), right bundle branch block, coiling and knotting, pulmonary artery rupture, and 
infection up to 72 hours of PAC insertion. Frequency and percentage were computed for 
gender, comorbids (Hypertension, Diabetes, Chronic kidney disease, Chronic Obstructive 
Pulmonary Disease) and PAC frequency of insertion, indications and complications were 
noted. Results: The frequency of PAC insertion was 47.83%. Major indications for PAC 
insertion were poor left ventricular function, acute coronary syndrome, cardiogenic shock, 
significant left main disease and valvular heart disease patients. Minor complications were 
found in 23.22% cases, which included arrhythmia in 19.2% cases and coiling in 4.02%. 
Conclusion: Pulmonary artery catheter insertion is a safe technique with useful clinical 
application in the management of high-risk cardiac surgical patients. The PAC insertion 
rationale must be standardized to confirm the judicious use.  
Keywords: Pulmonary artery catheter (PAC) insertion; Adult cardiac surgery; Complications 
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INTRODUCTION 
Patients presenting for cardiac surgery have 
unstable cardiovascular disease and 
haemodynamics with multiple coexisting diseases. 
Optimal monitoring in the perioperative period is 
very important for best perioperative outcome. The 
introduction of the flow-directed pulmonary artery 
catheter (PAC) into clinical practice is one of the 
most important and popular advances in the field 
of cardiac anaesthesia.1, 2  
PAC monitoring provides information 
about pulmonary artery occlusion pressure, cardiac 
output (CO), right atrial pressure, systemic 
vascular resistance and mixed venous O2 (SvO2) 
and help us in patients management and may 
reduce perioperative mortality and morbidity.3,4 It 
has been over used frequently without proper 
indications in both the operating rooms and the 
ICUs.5,6 There has been considerable controversy 
regarding the use of pulmonary artery catheter 
(PAC) in clinical practice because of its 
complications. In practice, PAC is still used with 
frequency of 35–68.2%7,8 and complication rate 
reported is around 5–10%9,10. 
Different alternate monitoring techniques 
can be used in open-heart cardiac surgery, but none 
has been proved to be a true replacement of PAC 
monitoring. Transoesophageal echocardiography 
(TEE) is a valuable monitoring technique both 
during and after cardiac surgery. However, its 
limitations are that it is a semi-quantitative method 
and it does not permit continuous monitoring. 
Different practices exist among the 
cardiac anaesthesia consultants and cardiac 
surgeons regarding the rationale for PA catheter 
usage. No local guidelines are available for the use 
of PA catheter insertion. Local data is not available 
regarding the frequency and rationale of PA 
catheter insertion in open-heart cardiac surgery 
patients in the developing countries like Pakistan 
where health care cost is a major factor. Every 
monitoring technique should be rationalized so as 
to take optimal advantage of its use economically 
and clinically. This audit will help us in gauging 
our clinical practice with international practice. 
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MATERIAL AND METHODS 
After taking approval from Ethical review 
committee (Approval no: 3792-Ane-ERC-15) and 
informed consent from the patients, this prospective 
observational study was conducted in Cardiac 
operating room and CICU of tertiary care hospital 
for a period of six months. All adult male and 
female elective, urgent and emergent open heart 
surgery patients including coronary artery bypass 
grafting (First time and Redo CABG), isolated 
Valve replacements (mitral valve replacements, 
aortic valve replacements), combined procedures 
(CABG plus Valve replacements) and aortic root 
replacements in the age group 18–80 years were 
included in the study. 
Patients with right atrial thrombus, 
endocarditis involving tricuspid and pulmonary 
valve, patients with severe pulmonary stenosis, and 
patients in which PAC retained for more than 72 
hours were excluded. 
Sample size calculation was based on 
previous studies, where insertion of pulmonary 
artery catheter (PAC) was reported in 35% 
patients.7,8 Therefore 207 patients were included to 
estimate the frequency of PAC insertion within 
6.5% level of precision with 95% confidence 
interval. Decision of PAC insertion was taken by the 
Anaesthesia consultant on list and if ambiguous in 
consultation with the Cardiac surgeon. PAC was 
inserted through internal jugular or subclavian vein. 
Pressure waveforms and filling chamber pressures 
guided the floatation of PAC. Complications noted 
were arrhythmias (atrial and ventricular), right 
bundle branch block, coiling and knotting, RV 
rupture, pulmonary artery rupture, and PAC related 
infection up to 72 hours post-operatively.  
All statistical analyses were performed 
using SPSS-19. Frequency and percentage were 
computed for gender, comorbids (HTN, DM, CKD, 
and COPD) and PAC frequency of insertion, 
indications and complications noted. Mean and 
standard deviation were also estimated for age, 
weight, height and BMI. Stratification was also 
performed to control the effect of age, gender, BMI, 
comorbid to observe the PAC frequency of 
insertion, indications and its complications. Chi-
square test was used; p≤0.05 was considered level 
of significance. 
RESULTS 
A total of 207 open-heart cardiac surgery patients 
were enrolled in this study, but 204 patients were 
followed for 72 hours because 3(1.45%) patients 
died during surgery and out of 3 patients only 2 
patients received PAC. Nine patients were not 
followed after 72 hours because PAC was retained 
beyond the standardized duration. Only one patient 
received PAC postoperatively due to eventful post-
pump course.  
The mean age of the patients was 57.76±11.59. 
There were 157 (75.85%) male and 50 (24.15%) 
female patients. Demographic data is elaborated in 
table-1. Most of the cases were CABGs (81.2%), 
13% were valve replacements 4.8% cases were 
combined procedures and only 1% were ASD 
closure.8.2% cases were emergent and all received 
PAC. Out of 207 patients, 99 (47.83%) were 
monitored with PAC. Major indications were 
analysed in the study shown in Figure-1.  
Minor complications were found in 23.22% 
cases, which included arrhythmia in 19.2%, and 
coiling was found in 4.02% cases. These 
complications were managed after withdrawing or 
manipulation of PAC; only one patient had recurrent 
arrhythmias in which PAC was removed 
postoperatively within few hours. No major 
complications like PA or RV rupture were found. 
 
Figure-1: Frequency and indications of 
pulmonary artery catheter (PAC) insertion in 
adult open-heart surgery patients 
 
Table-1: Demographic characteristics of patients 
(n=207) 
 Variables  
Age (Years) 57.76±11.59 
Weight (Kg) 71.66±11.78 
Height (cm) 163.54±7.29 
BMI (kg/m2) 26.78±4.07 
Gender 
Male 
Female 
 
157 (75.85%) 
50 (24.15%) 
Co-Morbid:  
Hypertension 
Diabetic Mellitus 
Ischemic heart disease 
Chronic kidney disease (CKD) 
Hypothyroidism 
Chronic obstructed pulmonary disease (COPD) 
Acute myocardial infarction (AMI) 
Other 
 
130 (62.8%) 
82 (39.6%) 
55(26.6%) 
10 (4.8%) 
7 (3.4%) 
6 (2.9%) 
4 (1.9%) 
6 (2.9%) 
Other: Asthma, Hepatits C, Valvular heart disease, Rheumatic 
heart disease, Acute kidney injury. 
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Table-2: Angiographic finding and procedure 
(n=207) 
Variables  n (%) 
Angiographic finding  
Grading of coronary artery disease 
Normal Vessel 
Single Vessel 
Double Vessel 
Triple Vessel 
 
 
25 (12.1) 
2 (1) 
15 (7.2) 
165 (79.7) 
Significant left main disease 
Yes 
No 
 
23 (11.1) 
184 (88.9) 
Ejection Fraction (%) 49.88±12.88 
Pulmonary Hypertension  
Mild 
Moderate 
Severe 
34 (16.4) 
17 
12 
5 
Procedure 
CABG 
Mitral valve replacement (2 of 15 redo MVR) 
Aortic valve replacement 
Double valve replacement   
CABG + AVR/MVR 
Atrial septal defect 
 
168 (81.2) 
15 (7.2) 
6 (2.9) 
6 (2.9) 
10 (4.8) 
2 (1) 
Urgency of procedure 
Elective 
Urgent 
Emergent 
 
181 (87.4) 
9 (4.3) 
17 (8.2) 
Results are presented as n (%) and mean±SD 
Table-3: Frequency of complications related to 
PAC insertion (n=99) 
Complications Frequency Percentage 
Arrhythmias: Atrial 
 (A. Fibrillation, A. flutter) 
9 9.1 
Ventricular  
(Pre-mature Ventricular 
Contractions, Ventricular –
Tachycardia. V- Fibrillation.) 
10 10.1 
Coiling 4 4.04 
 
Table 4: Comparison of characteristics with and 
without PAC  
Variables 
PAC 
Used 
n=99 
PAC 
Not Used 
n=108 
p-values 
Age (Years) 56.43±13.19 58.98±9.80 0.11 
Weight (Kg) 70.27±11.89 72.94±11.58 0.10 
Height (cm) 162.84±7.52 164.18±7.0 0.18 
BMI (kg/m2) 26.55±4.64 26.99±3.49 0.44 
Gender 
Male 
Female 
 
72 (72.7%) 
27 (27.3%) 
 
85 (78.7%) 
23 (21.3%) 
0.31 
Co-Morbid:  
Hypertension 
Diabetic Mellitus 
IHD 
CKD 
Hypothyroidism 
COPD 
AMI 
Other 
 
62 (62.6%) 
43 (43.4%) 
26 (26.3%) 
10 (10.1%) 
6 (6.1%) 
4 (4%) 
3 (3%) 
5 (5.1%) 
 
68 (63%) 
39 (36.1%) 
29 (26.9%) 
0 (0%) 
1 (0.9%) 
2 (1.9%) 
1 (0.9%) 
1 (0.9%) 
 
0.96 
0.28 
0.92 
0.001 
0.041 
0.34 
0.27 
0.07 
Table-5: Comparison of Angiographic finding and 
procedure with and without PAC (n=207) 
Variables  
PAC Used 
n=99 
PAC 
Not Used 
n=108 
p-Value 
Angiographic finding  
Grading OF CAD 
Normal Vessel 
Single Vessel 
Double Vessel 
Triple Vessel 
 
 
22 (22.2%) 
1 (1%) 
6(6.1%) 
70 (70.7%) 
 
 
3 (2.8%) 
1 (0.9%) 
9 (8.3%) 
95 (88%) 
 
 
0.0005 
0.99 
0.59 
0.002 
Significant left main disease 
Yes 
No 
 
16 (16.2%) 
83 (83.8%) 
 
7 (6.5%) 
101 (93.5%) 
0.027 
Ejection Fraction (%) 44.60±14.24 55.11±8.68 0.0005 
Pulmonary Hypertension  
Mild 
Moderate 
Severe 
23 (23.2%) 
8 
10 
5 
11 (10.2%) 
9 
2 
0 
0.011 
Procedure 
CABG 
MVR (2 of 15 redo MVR) 
AVR 
DVR  
CABG + AVR/MVR 
ASD 
 
67 (67.7%) 
14 (14.1%) 
5 (5.1%) 
6 (6.1%) 
7 (7.1%) 
0 (0%) 
 
101 (93.5%) 
1 (0.9%) 
1 (0.9%) 
0 (0.0%) 
3 (2.8%) 
2 (1.9%) 
 
0.0005 
0.0005 
0.106 
0.011 
0.19 
0.49 
Urgency of Procedure 
Elective 
Urgent 
Emergent 
 
73 (73.7%) 
9 (9.1%) 
17 (17.2%) 
 
108 (100%) 
0 (0%) 
0 (0%) 
0.0005 
DISCUSSION 
Pulmonary artery catheter was proudly announced 
first in 1970,11 then grew rapidly and gained 
popularity till 1986, after that it was challenged in 
clinical practice. There has been considerable 
controversy regarding the use of pulmonary artery 
catheter (PAC) in clinical practice.12,13 Many studies 
have indicated poor outcome in patients who were 
monitored with PAC.10 However, these studies, that 
have condemned the use of PAC, were conducted on 
patients in intensive care units, where the clinical 
scenarios with regard to patients clinical status were 
somewhat different as compared to those of  cardiac 
operating room.9 Although some studies disapproved 
PAC in cardiac surgery6,8 but still studies proved that 
PAC is used more as monitoring tool in cardiac 
surgery than any other monitoring devices14. The use 
of PAC in cardiac surgeries varies considerably from 
a routine use to no PAC at all and majority follow 
indications, which we followed in this study. 
Although guidelines for PAC insertion are available 
in non-cardiac surgeries, 15 none are available for 
adult cardiac surgical patients undergoing open-heart 
procedures. 
No PAC related study has been conducted in 
cardiac surgery patients in Pakistan. Our institution is 
one of the leading centres for cardiac surgeries in 
Pakistan, where around 800–1000 adult open-heart 
surgeries are performed yearly. We routinely use 
PAC for monitoring in high risk cardiac surgery 
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patients including Acute coronary syndrome, valve 
replacements, poor LV and cardiogenic shock, 
therefore we had designed and conducted this study 
to share our experience about PAC with respect to its 
frequency of insertion, indications and complications. 
In our clinical practice, PAC insertion has been found 
to be very useful in differentiating between 
cardiogenic and vasoplegic shock. PAC also helps in 
rational and objective use of inotropes and 
vasopressors. 
The current study showed that PAC was 
used in 47.83% of enrolled cases of which majority 
were elective triple vessel coronary artery disease 
patients scheduled for CABG. We used PAC in 
almost all valve replacement surgeries and 
emergent/urgent cardiac surgeries. Surgeon choice 
was found in very few cases. There were few cases in 
which we didn’t use PAC despite poor LV function. 
There were no major complications except 
arrhythmias 19.2% and coiling 4.04% of patients, all 
of which were settled by just withdrawing or re-
adjustment of catheter. Literature showed that rate of 
major complications related to PAC is low in cardiac 
surgery and also when inserted and managed by an 
experienced Anaesthesiologist/Intensivist.16. There is 
wide range of complications mostly related to 
arrhythmias 12.0–70% reported.16 Other 
complications like thrombosis (8–22%), endocarditis 
(2.2-7.1%), PA rupture (0.03–0.20%), knotting 
(0.03%), sepsis (1.3-2.2%) were reported in western 
literature.16,17 If we compared this study with the 
other study on PAC in ICU conducted at Aga khan 
university hospital in 2006, the frequency of PAC 
insertion was 19% and complication rate was 30%.18 
We did not analyze the cost of PAC in 
cardiac surgery but roughly it cost about 15,000–
17,000 PKR per PAC, so in developing country like 
Pakistan risk and benefit ratio should be considered 
while placement of PAC. 
In cardiac surgeries there are some other non-invasive 
or semi invasive cardiac output monitoring devices 
available like Pulse index continuous cardiac output 
(PiCCO), lithium dilution cardiac output (LidCO), 
Bio-impedance, Oesophageal Doppler, with very 
limited data available.14 Among all of these 
monitoring devices Trans-oesophageal 
echocardiography (TEE) is an alternating tool for 
monitoring in cardiac surgery.19 TEE is one of the 
evolving modality with standard of care application 
in many international cardiac centres. TEE needs 
expertise and experience for continual monitoring. At 
present, cardiac Anaesthesiologist’s choice of PAC or 
TEE monitoring is strongly influenced by their 
expertise and availability. PAC and TEE are not 
competitors; albeit they are subsidiary monitoring 
tools. Of course, the definition of correct use and a 
correct indication may vary according to local policy, 
economic considerations and the patient population. 
The limitation of the study is that it is a 
prospective observational study with no comparison 
with any other cardiac monitoring modality and no 
standardization in the choice of PAC. The choice of 
PAC insertion was predominantly at the discretion of 
the cardiac anaesthesiologist. The study was limited 
to 72 hours’ post-operative period with no data 
collection of long-term mortality and morbidity.  
CONCLUSION 
Pulmonary artery catheter insertion is safe technique 
with useful clinical application in the management of 
high-risk cardiac surgical patients. Risk benefit ratio 
must be considered during the selection of PAC 
insertion. The PAC insertion rationale must be 
standardized to confirm the judicious use.  
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